เอกสารอ้างอิง
[1]. Centers for Disease Control and Prevention. COVID-19 Vaccines for Children and Teens [Internet]. 2021 [cited 2021 Nov. 14]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/children-teens.html.
[2]. World Health Organization. Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing [Internet]. 2021 [cited 2021 Nov. 25]. Available from: https://apps.who.int/iris/rest/bitstreams/1394294/retrieve.
[3]. World Health Organization. COVID-19 advice for the public: Getting vaccinated [Internet]. 2021 [cited 2021 Nov. 25]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice.
[4]. ราชวิทยาลัยกุมารแพทย์แห่งประเทศไทย. คําแนะนําการฉีดวัคซีนป้องกันโรคโควิด-19 สําหรับเด็กและวัยรุ่นอายุตั้งแต่ 12 ปีขึ้นไป (ฉบับที่ 3) [อินเทอร์เน็ต]. 2564 [เข้าถึงเมื่อ 15 พ.ย. 2564]. เข้าถึงได้จาก: https://www.thaipediatrics.org/Media/media-20210927030328.pdf.
[5]. Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N. Engl. J. Med. 2021 Jul. 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May. 27. PMID: 34043894; PMCID: PMC8174030.
[6]. Olson SM, Newhams MM, Halasa NB, Price AM, Boom JA, Sahni LC, et al. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021. MMWR. Morb. Mortal. Wkly. Rep. 2021 Oct. 22;70(42):1483-1488. doi: 10.15585/mmwr.mm7042e1. PMID: 34673751.
[7]. Bozkurt B, Kamat I, Hotez PJ. Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021 Aug. 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul. 20. PMID: 34281357; PMCID: PMC8340726.
[8]. Dionne A, Sperotto F, Chamberlain S, et al. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA. Cardiol. Published online August 10, 2021. doi:10.1001/jamacardio.2021.3471.
[9]. Das BB, Kohli U, Ramachandran P, Nguyen HH, Greil G, Hussain T, et al. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J. Pediatr. 2021 Nov.;238:26-32.e1. doi: 10.1016/j.jpeds.2021.07.044. Epub 2021 Jul. 30. PMID: 34339728; PMCID: PMC8321962.
[10]. Centers for Disease Control and Prevention. Pfizer-BioNTech [Internet]. 2021 [cited 2021 Nov. 14]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html.
[11]. Melbourne Vaccine Education Centre. G6PD deficiency and vaccines [Internet]. 2021 [cited 2021 Nov. 14]. Available from: https://mvec.mcri.edu.au/references/g6pd-deficiency-and-vaccines/.
[12]. Centers for Disease Control and Prevention. Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults [Internet]. 2021 [cited 2021 Nov. 20]. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html.